Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges

A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation

(2014) J.W. Hooper et al.   CLINICAL MICROBIOLOGY AND INFECTION

A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates

(2014) Steve Kwilas et al.   CURRENT GENE THERAPY

Tibetan plateau gets wired up for monsoon prediction

(2014) Jane Qiu   NATURE

Emergence of Zaire Ebola Virus Disease in Guinea

(2014) Sylvain Baize et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

(2013) A. Marzi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)

(2013) Jay W. Hooper et al.   VACCINE

DNA vaccines for HFRS: Laboratory and clinical studies

(2013) Connie S. Schmaljohn et al.   VIRUS RESEARCH

Animal models for Ebola and Marburg virus infections

(2013) Eri Nakayama et al.   Frontiers in Microbiology

Construction and Nonclinical Testing of a Puumala Virus Synthetic M Gene-Based DNA Vaccine

(2012) R. L. Brocato et al.   Clinical and Vaccine Immunology

Protective Efficacy of Neutralizing Monoclonal Antibodies in a Nonhuman Primate Model of Ebola Hemorrhagic Fever

(2012) Andrea Marzi et al.   PLoS One

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease

(2012) J. M. Dye et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

(2012) G. G. Olinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies

(2012) X. Qiu et al.   Science Translational Medicine

A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome

(2012) Ellen F. Boudreau et al.   VACCINE

A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge

(2012) Rebecca J. Grant-Klein et al.   Human Vaccines & Immunotherapeutics

Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus

(2012) Gopi S. Mohan et al.   PLoS Pathogens

A DNA Vaccine for Venezuelan Equine Encephalitis Virus Delivered by Intramuscular Electroporation Elicits High Levels of Neutralizing Antibodies in Multiple Animal Models and Provides Protective Immunity to Mice and Nonhuman Primates

(2011) Lesley C. Dupuy et al.   Clinical and Vaccine Immunology

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

(2011) Nancy J Sullivan et al.   NATURE MEDICINE

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations

(2010) Jens H. Kuhn et al.   ARCHIVES OF VIROLOGY

Biochemical and Structural Characterization of Cathepsin L-Processed Ebola Virus Glycoprotein: Implications for Viral Entry and Immunogenicity

(2010) C. L. Hood et al.   JOURNAL OF VIROLOGY

Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates

(2010) Lesley C. Dupuy et al.   VACCINE

Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms

(2010) Devon J. Shedlock et al.   VIROLOGY

Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats

(2009) Jonathan S. Towner et al.   PLoS Pathogens

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

(2008) D. L. Swenson et al.   Clinical and Vaccine Immunology

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

(2008) Jeffrey E. Lee et al.   NATURE

Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters

(2008) Kristin W. Spik et al.   VACCINE